In short
How the U.S. right, especially Trump-aligned figures, moved psychedelics into the mainstream—centered on Ibogaine—and pushed policy changes via an executive order.
Guest backgrounds
Maytha Busby is a British journalist who covers drug policy and has written about shifting U.S. psychedelic attitudes. She also personally took Ibogaine at a clinic in Cancun for a journalism story.
Key claims
Ibogaine is a Schedule I drug extracted from West African (Gabonese) root bark; limited studies suggest potential for opioid withdrawal/addiction treatment and possible PTSD/TBI help. The Trump administration’s executive order would fund research (including $50M), expand “Right to Try” access for end-of-life patients, and fast-track some applications. The shift is attributed to veteran and conservative advocacy plus media influence (notably Joe Rogan).
Notable examples
Busby’s 12-hour “white knuckle” dissociative trip with IV monitoring; a clinic death shortly after opening; veterans’ claims like stopping opioids, improved sleep, and ending alcohol dependence; discussion of Ibogaine’s cardiac QT-risk and reported deaths.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOUnderstanding Ibogaine and Its Context
0:48 to 2:52
A discussion on Ibogaine, its effects, and the political landscape surrounding its legalization.
“Maytha Busby is a journalist who covers drug policy.”
The Role of Joe Rogan in Psychedelic Policy
2:53 to 4:36
Exploring Joe Rogan's influence on the psychedelic movement and its connection to the Trump administration.
“So it's like an extracted molecule from a West African, Gabonese specifically, root bark from a shrub.”
Executive Orders and Psychedelic Research
4:37 to 8:01
Details on executive orders regarding psychedelic drug research and potential impacts on policy.
“I mean, so he's had figures on his podcast since it began, right?”
Veteran Stories and the Case for Ibogaine
8:02 to 12:50
Discussing the impact of Ibogaine on veterans and the broader implications for drug policy.
“So that would open the floodgates more widely to research.”
Personal Experience with Ibogaine
17:36 to 19:20
Maitha shares her journey and experience with Ibogaine.
“I guess there was an element of curiosity, and I figured it could make for quite a compelling story.”
Understanding Ibogaine and Its Uses
19:23 to 21:47
Discussion on the historical context and potential benefits of Ibogaine.
“And, you know, you're fully, like, wired up.”
Challenges in Ibogaine Research
21:48 to 23:53
Exploration of the difficulties in studying Ibogaine and its effects.
“And, you know, the other psychedelics have maybe found, you know, simpler passage towards, you know, getting approvals for studies.”
Veteran Experiences with Psychedelics
23:54 to 26:06
Sharing of veterans' stories on how psychedelics have impacted their lives.
“I mean, one of the, there was a couple of, well, several people behind Trump when he made the announcement who he got them to share their stories.”
Transcript
Automatic transcript. May contain errors.0:03Jonquilyn Hill:The Trump administration is all in on legalizing a psychedelic drug called Ibogaine. And it is a major trip. It was like the ultimate ass-kicking. It was miserable. Like, I was thrown up. It's classified as a Schedule I drug, which means it's illegal on the federal level. But a couple studies show it may be able to treat opioid addiction. And some researchers are hopeful that it can help with PTSD. That's got the attention of President Trump and a certain popular podcaster, which means Ibogaine's having a moment. Today on the show, how the right got into psychedelics and the story of how they're pushing the Trump administration to legalize them.
0:47Jonquilyn Hill:Strap in. We're going on a trip.
1:19We'll see you next time. You can do that, do that, do that, do that with Acrobat Learn more at adobe.com slash do that with Acrobat What's up y 'all, I'm Skylar Diggins, seven time WNBA all star, Olympic gold medalist, and mom And I'm Cassidy Hubbard, host and reporter for nearly 20 years covering the biggest names and stories in sports And mom And this is And Mom, a community for athletes, game changers, and moms of all kinds It's dropping May 14th. Tap in with us.
1:57Jonquilyn Hill:It's Today Explained. I'm John Glynhill, sitting in. Maytha Busby is a journalist who covers drug policy. He's also British, so he says Ibogaine in a classier way than those of us on this side of the pond. Recently, he's been writing about the shifting attitudes on psychedelic drug policy in the U.S. And one of the biggest shifts is coming from the president. Well, you know, he's famously never smoked a cigarette, had a drink, certainly not had a trip. So, you know, in the Oval Office the other week, he's kind of joking about taking Ibogaine. I'll take whatever it takes. I don't have time to be depressed.
2:36And there's a lot of bravado there. But, you know, this Ibogaine is an incredibly potent psychedelic. It famously gives people sort of recalls of every traumatic moment in their life. So, you know, I'm sure we'd all love to see Trump subject himself to that sort of experience.
2:52Jonquilyn Hill:What is Ibogaine? So it's like an extracted molecule from a West African, Gabonese specifically, root bark from a shrub. And basically it became known as being able to rid opioid addicts, heroin addicts of withdrawal symptoms, you know, in one trip. Yeah. Ibogaine has now entered the mainstream conversation with the Trump administration talking about legalizing certain psychedelics. How did we get here? Yeah, I mean, psychedelics obviously long belonged to the cultural left, the counterculture. We would all like to be able to live an uncluttered life, a simple life, a good life, you know, and like think about moving the whole human race ahead a step.
3:45And one of the ways of achieving that being is through drugs. But it seems now there's almost like a counter-culture with these sort of, you know, right-wing, sort of conservative, mostly Christian, former, you know, special forces fighters, soldiers in the U.S. Army that, you know, are suffering from really debilitating conditions from PTSD and TBI. And they've basically figured out that Ibogaine and indeed other psychedelics provides them the relief that conventional medicines don't.
4:21Jonquilyn Hill:Okay, there's been a flurry of activity in this last month around psychedelics. And it had to do with, you know, who I consider the political kingmaker of the moment. And that's Joe Rogan. How is Joe Rogan involved in the policymaking here? I mean, so he's had figures on his podcast since it began, right? Talking about psychedelics. Rick Doblin, who is the head of MAPS or Multidisciplinary Association for Psychedelic Studies. You know, the original sort of bro-cast dude, Aubrey Marcus. What's going on, man? What's going on in your shirt? What is that? Got a lot going on there. Oh, yeah. It's like a penguin with shark teeth.
4:59This is my homage to Albert Hoffman in the creation of LSD. Oh, wow. All through till today. And he's had the former Texas governor and Trump's first energy secretary, Rick Perry, on his podcast twice, along with a Kentucky lawyer and immigrant advocate named Brian Hubbard, who sort of sounds like a Christian Southern revivalist. Every human being has stardust running through their blood. And the movement that Governor Perry and I are leading is one that aims to recognize the reality of that human divinity. And always quotes his favorite passage out of Isaiah. And we will crawl the last mile to deliver good tidings unto the meek, to bind up the brokenhearted, to proclaim liberty to the captives and the opening of the prison to them that are bound.
5:53And so Joe Rogan had, you know, this unlikely duo, you know, who have both done Ibogaine and a waxing lyrical about the benefits. He had them both on his podcast, like three weeks before the executive order. And they basically said, look, you know, Joe, we need to make this happen. So Joe texts Donald Trump and apparently Donald Trump responds almost instantaneously saying, you know, sounds good. Do you want FDA approval?
6:19Jonquilyn Hill:That's all it takes? Allegedly. I mean, you know, they are accelerating the processes. And if you do see, you know, this kind of cast of guys behind Trump, you know, there's a real cast of personalities like perhaps we've never seen before. This all culminates with Joe Rogan actually going to the White House to attend the signing of an executive order about psychedelics. What's in that executive order? Well, I mean, the thing about executive order is it's sort of, you know, shouting into the wind a bit. But there is this money to go into the research side. And, you know, let's not forget, these are Schedule 1 drugs.
6:57You know, ever since Richard Nixon, a fellow Republican, declares the war on drugs. And really, this is the biggest green light yet for, you know, potentially multi-billion dollar industry. I mean, it had like five or six prongs. One of the main ones is that now under right to try laws that Trump introduced in his first term to allow basically end of life patients to try experimental drugs, that will be extended to psychedelics so long as the DEA don't kind of try and obstruct that process. There's 50 million for psychedelic research, most of which it seems are going to support state-led initiatives to investigate Ibogaine and allow a sort of US first human trial.
7:43And also, it's accelerating the path to a potential approval for psychedelic drugs. And a week after, three candidates that had just submitted their data got sort of fast-tracked, you know, potential approvals. So, you know, their applications will be considered more quickly. So that would open the floodgates more widely to research.
8:08Jonquilyn Hill:Do you expect the FDA to say, this is great, go ahead, use psychedelic drugs? they will help you. Like, what can we expect from regulators on this? Yeah, I think that it's quite likely, really, within this presidency, you know, to see several, you know, psychedelic drugs approved now, which is, you know, a huge, a huge development, really. I mean, Joe Biden, there was talk about him setting up a federal task force and helping stuff along there. And, you know, he didn't seem to put any political will behind it. So, you know, Trump has really kind of seized the mantle here and he's sort of surfing the zeitgeist as he weirdly seems to be able to on, you know, certain topics, all the while sort of outraging and, you know, provoking us along the way.
8:57Jonquilyn Hill:There does seem to be some dissonance here, though. I mean, you mentioned Nixon before. The GOP traditionally was all about the war on drugs. America's public enemy number one in the United States is drug abuse. They are bombing boats in South America over drugs. What is up with this switch up? Yeah, I mean, cocaine use in the US is actually going down quite significantly. So the whole thing with, you know, bombing these fishermen boats is just, you know, crazy and completely illegal. but you know it is a geopolitical tool i don't i don't think they really care about kind of minimal cocaine imports they they wanted regime change in venezuela and and you know for decades drugs the specter of drugs has been a useful um straw man to get involved in latin america there's a lot of dissonance i think that you know broadly though we're seeing the war on drugs coming to an end little by little, even despite the rhetoric here and there.
9:59And, you know, I think this is a significant threshold moment. Trump's always been kind of outside the Republican Party sort of establishment, to some extent, you know, compared to some other figures, previous presidents. It's not like it's been some sort of like topsy-turvy, you know, issue. The Democrats, when they've come in, there's been piecemeal, you know, changes. You know, I mean, Joe Biden himself introduced the laws when he was a senator, you know, to make the punishments for crack cocaine, which is obviously more likely used by people of color. If you have a piece of crack cocaine, no bigger than this quarter that I'm holding in my hand, one quarter of one dollar, we passed a law through the leadership of Senator Thurman and myself and others, a law that says, if you're caught with that, you go to jail for five years.
10:56You know, the penalty is like 30 times more stringent than for powder cocaine, which is used more often than, you know, white people. So I think that there's been a bipartisan issue, really, the war on drugs.
11:08Jonquilyn Hill:Do we know who's using psychedelics? You mentioned that demographic breakdown. Do we have any idea about this class of drugs? I think, you know, the interesting thing with psychedelics now, as opposed to maybe 10-15 years ago, is that sort of, you know, they've crossed the political divide. I think that, you know, a lot of people from unexpected segments of society are getting turned on because, you know, they are seeing, you know, broadly the benefits, even while there are serious risks, especially with Ibogaine. Mm. So there was only one drug named in that executive order, and it was Ibogaine.
11:51Jonquilyn Hill:Why? The veterans, you know, these stories from veterans about the transformative effects of Ibogaine have been really difficult to refute politically. 22 veterans, on average, are committing suicide in the US every day. And Trump in the Oval Office, when he signed the order, said, Since 9-11, we've lost over 21 times more veteran lives to suicide than on the battlefields. There's so many congressmen and senators who are veterans themselves. There was a study from Stanford a couple of years ago that looked at 30 ex-special forces and, you know, found that a dose of Ibogaine reduced all of their traumatic brain injury significantly.
12:37but, you know, we shouldn't be under any illusions. This is a seriously potent and dangerous psychedelic when, you know, used improperly, and there's been a whole spate of deaths. Indeed, the deaths are probably underreported because the drug sort of disrupts the QT interval in the heart and can lead, you know, in some cases to, you know, fatal cardiac arrest.
13:14Jonquilyn Hill:Coming up, we sit in the passenger seat for an Ibogaine trip.
13:32Support for the program today comes from Found. Any small business owner can tell you that managing your finances can get chaotic fast. A bank account here, QuickBooks there, plus taxes and invoicing tools layered on top. Before long, you're juggling costly software, falling behind on your books, and unsure where your business really stands. That's where Found says they can help. Found says they can cut through the clutter by bringing everyone into one platform, banking, bookkeeping, invoicing, and taxes all in one place. That means no more paying for multiple subscriptions or dealing with outdated clunky tools.
14:04Found even says that you can send invoices for free and pay contractors all from a single app. Found says that they're built to help you take back control of your business finances. So you can focus on what you actually love running your business. You can take back control of your business today. You can open a Found account for free at found.com. That's F-O-U-N-D.com. Found is a financial technology company, not a bank. Banking services are provided by a lead bank member, FDIC. You can join the hundreds of thousands who've already streamlined their finances with Found.
14:37Support for the show comes from Chime. Banking can sometimes feel like you're playing a game of dodgeball. Love dodgeball. Doing everything in your power to not get hit with overdraft fees, minimum balance requirements, and monthly fees. Don't love that. Chime wants to help. They say that they're approaching things differently and changing the way people bank. Chime says they are offering you the most rewarding fee-free banking, banking built for you. Why pay to get your own money? They're not looking to charge you overdraft and or monthly fees. And they have thousands of fee-free ATMs for you to use built for you, not the 1%.
15:09Take that 1%. Chime members can even benefit from up to$1 ,150 in annual rewards fee-free. Plus direct deposit unlocks the most rewarding way to bank at Chime. Chime says they're not just smarter banking. They're the most rewarding way to bank. You can join the millions who are already banking fee-free today. It just takes a few minutes to sign up. head to chime.com slash explained. That's chime.com slash explained. Chime is a financial technology company, not a bank. Banking services and the secured Chime Visa credit card are provided by the Bancorp Bank N.A. or Stride Bank N.A. Optional services and products may have fees or charges.
15:40See chime.com slash fees info. Terms apply. Limited time only. Must open the new account and complete qualifying activities to earn rewards. Advertised annual percentage yield with Chime Plus status only. Otherwise, 1 % APY applies. No minimum balance required. Chime card on-time payment history may have a positive impact on your credit score. Results may vary. See chime.com for details on applicable terms.
15:58Support for the show today comes from Vanta. If you're a business owner, you may have noticed a shift recently. Risk and regulation are increasing, but before they sign anything, customers now expect clear proof of security. Building that trust is essential to closing deals, and that's what we're all about, closing deals, but it's also complex, expensive, and time-consuming. Vanta says they can automate that process to bring compliance, risk, and customer trust together on one AI-powered platform. So whether you're prepping for a SOC 2, and who isn't, or running an enterprise GRC program, I know a lot of you are, Vanta keeps you secure and keeps your deals moving.
16:39This helps companies get compliant fast and remain compliant in the future, opening doors to huge growth opportunities and freeing up your valuable time. You can get started at Vanta.com slash explained. That is V-A-N-T-A dot com slash explained. Vanta.com slash explained.
17:13Jonquilyn Hill:You're listening to Today Explained. Maitha, you've taken Ibogaine. what led you to that moment? So, you know, I don't think I'd necessarily do it again. Oh. I mean, it was a different period in my life, I guess. Like, doing it for journalism, in a way, right? It was four years ago. I guess there was an element of curiosity, and I figured it could make for quite a compelling story. It was, at the time, like, more professional Ibogaine clinics were opening up and you know I had like a source for another story who was just opening a clinic so he reached out to me and at the time I hadn't really heard anything about it and he was telling me that it can yeah wipe out addiction and for people having you know crazy withdrawal symptoms right like if they don't take their opioid they're like healing over they're super sick and he was just sort of telling me that the kind of miraculous effects of it and And I wanted to see it for myself and I was curious to experience it for myself.
18:18So I go down to this clinic in Cancun. The doctor comes in and he gives me like nine capsules of this, you know, root bark extract and gives a long spiel about how lucky we are and, you know, what an amazing journey we're going to have. And really, it was a, you know, a kind of white knuckle ride. like it's intensely dissociative. So I had all sorts of kind of fantastical visions. And yeah, I think the key thing for me was like, not to sound too woo, but it really like connected me to like my parents and the gift of life really. And so, yeah, luckily I was able to convey that to my father before he passed away.
19:02So, you know, but the crazy thing was is that a guy who arrived on my penultimate day and he was like, you know, he just relapsed. after a few years clean. But yeah, he dies after his Ibogaine trip at the same clinic. So, I mean, that's part of the reason I might not do it again, right?
19:23Jonquilyn Hill:How long was your trip? It's like 12 hours. And, you know, you're fully, like, wired up. Like, I had the IV in, a heart rate monitor on my chest and my fingers. I mean, I think they actually gave me a relatively mild dose. I think they actually were in some ways like risk averse, although, you know, not so much that they couldn't avoid a death shortly after their opening. But yeah, then it kind of, you know, winds down. But you literally can't stand up for like three or four hours. They call it like on the floor. Oh, my. OK, so what is Ibogaine then? You know, I've heard of magic mushrooms, their mushrooms.
20:02Jonquilyn Hill:What is Ibogaine? Where does that come from? So, I mean, originally there's a whole tradition around its use in Gabon. There's a religion, Bwiti, that is hundreds of years old. I mean, exactly how old is unclear. I think they only do like one big Iboga trip. It's like a coming of age ritual in the beginning of someone's life. And then after that, they don't take such a huge dose again. And then in the early 20th century, French chemists were researching a depression drug. And yeah, they extracted Ibogaine. And yeah, decades later, Howard Lotsoff takes Ibogaine by accident, basically. He was a heroin addict in New York and realizes that he has no withdrawal symptoms.
20:56And then so he sets about on this crusade, a decades-long crusade, to get Ibogaine to addicts.
21:03Jonquilyn Hill:So there's a lot of talk about Ibogaine in particular when it comes to mental health. Do we know that it helps with mental health issues? Well, the research is in its early days. It really is. There's been a few observational studies, mostly for PTSD and traumatic brain injury. and obviously you've got this you know long and storied use in Gabon so yeah it's difficult to say from a scientific perspective with much certainty obviously this administration are putting a lot of onus on kind of stories right like if they say it works it must work but yeah clearly it needs you know a huge amount more research but it's difficult because it's been in schedule one.
21:52And, you know, the other psychedelics have maybe found, you know, simpler passage towards, you know, getting approvals for studies. But even Ibogaine, you know, has been repeatedly blocked because of these cardiac risks that I mentioned.
22:09Jonquilyn Hill:I was reading up on Ibogaine and I saw that it's kind of behind other psychedelics when it comes to solid research. Why is that? Well, basically, I guess when Howard Lotshoff was trying to, you know, get it through in the 80s, there were deaths happening in the underground. And so they didn't get the approvals. And, you know, because the sort of people that really want to do Ibogaine are, you know, people suffering from some of the most extreme afflictions possible so they're coming into it in quite a fragile state quite often and i guess you know to ensure the study it also might be quite expensive um you know this is a perilous but promising drug and we had decades of the war on drugs and stigmatization and obviously some of the the you know the scare stories let's say about lsd for example are and were true right like if you do a huge amount of lsd it might send you crazy or or unearth you know craziness that you've got lurking inside of you so you know this isn't for the faint-hearted and should be done in a sensible fashion and we don't really have any sort of prevailing or kind of guiding wisdom really in society.
23:42So it has kind of been the blind leading the blind and it seems like their efforts are finally seeing some success.
23:53Jonquilyn Hill:What have Ibogaine advocates told you about the drug drug and what it's done for them. I mean, one of the, there was a couple of, well, several people behind Trump when he made the announcement who he got them to share their stories. It fixed my demonic relationship with alcohol. It saved my life and then it saved my wife. So every day is a blessing. This treatment saved my life as well. And so many fellow veterans helped me get off opiates, stopped using a nerve stimulator I hadn't waited, sleep for the first time in over 10 years. It absolutely changed my life for the better. I went through a lot of the programs that the veterans are going through, and I always kind of felt like I was a victim coming out of the program.
24:33When I came out of this, I felt like I had gotten my life back. That was five years ago.
Read the full transcript
24:38Jonquilyn Hill:Not too long ago, I was in physical therapy and I would get dry needling through it. That's when they take the needle, put it in the muscle, jiggle it around. And I would always joke with my physical therapist, oh my gosh, this is going to be the thing that fixes me. This is going to fix all of my problems. Everything's going to be better. This is going to be the thing that like fixes me. And I think people are seeking that from psychedelics. Is this the solution for a lot of people? Is this the thing that's going to fix them? I mean, I'm not seeking to be any sort of psychedelic Pied Piper. And clearly there's a huge placebo effect, like across the board, like with any sort of drug.
25:23I think though, as I said, these veteran stories are very difficult to refute when they've tried every possible treatment option and found no relief. And then they've done this and it has indeed given them relief. But for many other people, they don't necessarily find lasting relief. I interviewed this one lady for The Guardian a couple of years ago who has a serious form of anorexia. And one MDMA trip, she said, had given her a 10-year remission, but then she's since relapsed. And although she regularly does psychedelic therapy, she's still suffering from anorexia, you know. So this isn't a panacea, but there's a lot we don't know.
26:06And actually, I think that psychedelics are kind of a portal into some sort of spirit realm. People report these visions of entities, sometimes seemingly demonic or with some sort of malevolent intent. And if you do kind of listen to the indigenous thought leaders, you know, about what they think all of that represents, it really does boggle the mind. So I think that there's a lot, you know, we can learn in the West from, you know, indigenous understandings of psychedelics, you know, to ensure, you know, we don't have a bad trip.
26:55Jonquilyn Hill:If the Trump administration actually legalizes Ibogaine, there may be more trips ahead. May the Busby is a journalist covering drug policy. This episode was produced by Kelly Wessinger with an assist from Danielle Hewitt. It was edited by Miranda Kennedy along with Jolie Myers, fact-checked by Gabriel Donatov, and engineered by David Tattashore and Bridger Dunagan. I'm John Glyn Hill, and this is Today Explained.
27:25Thank you.
From the publisher
The MAGA right is enthusiastically embracing a potent psychedelic called ibogaine. Its the new counter-counter-culture.
This episode was produced by Kelli Wessinger with help from Danielle Hewitt, edited by Miranda Kennedy with help from Jolie Myers, fact-checked by Gabriel Dunatov, engineered by David Tatasciore and Bridger Dunnagan, and hosted by Jonquilyn Hill.
President Donald Trump signing an executive order to further medical research for certain psychedelic drugs, with Human Services Secretary Robert F. Kennedy Jr., podcaster Joe Rogan, and W. Bryan Hubbard, CEO of Americans for Ibogaine looking on. Photo by Jim WATSON / AFP via Getty Images.
Listen to Today, Explained ad-free by becoming a Vox Member: vox.com/members. New Vox members get $20 off their membership right now. Transcript at vox.com/today-explained-podcast.
Learn more about your ad choices. Visit podcastchoices.com/adchoices




